Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-09-23FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2016-09-19FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Effect of Pharmaceutical Care in Patients With Bipolar I Disorder (BD I) [NA]
The document reports results from a completed clinical trial evaluating the impact of pharmaceutical care in patients with Bipolar I disorde…
-
CLINICAL_TRIALS research · 2016-09-16Clinical Trial Update: Study of the Effectiveness of Specific Training of Health Professionals on Adherence in Bipolar Disorder [NA]
This entry notes a clinical trial evaluating the effectiveness of targeted training for health professionals to improve adherence in bipolar…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Depression And Bipolar Disorder [Phase 3]
Phase 3 clinical trial investigating treatment for bipolar disorder has completed enrollment/status according to the update.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: A Brief Family-centered Care Program for Bipolar Disorder [NA]
The clinical trial evaluating a brief family-centered care program for bipolar disorder has completed.
-
FDA approval · 2016-09-12FDA Approved: ARIPIPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved the original ANDA for a generic aripiprazole from Quallent Pharmaceuticals Health LLC. The approval covers a generic versio…
-
FDA approval · 2016-09-02FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for lamotrigine from Alembic Pharmaceuticals Limited under an ANDA. This action represents a minor r…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) [NA]
A completed clinical trial (CapiCor) evaluated the effectiveness of a physical activity and diet program for people with psychotic disorders…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Bipolar Study in Adults at Least 18 Years of Age [Phase 4]
Phase 4 clinical trial update for bipolar disorder in adults 18 and older; the study sponsored by GlaxoSmithKline has completed.
-
FDA approval · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action confirms approval …
-
FDA label_change · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA supplemental application for chlorpromazine hydrochloride filed by Upsher-Smith Laboratories, LLC, related to labeling changes.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 [Phase 3]
Open-label extension study assessing long-term safety, tolerability, and effectiveness of lurasidone added to lithium or divalproex in adult…
-
FDA approval · 2016-08-18FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approves a supplemental application for ABILIFY MAINTENA (aripiprazole) from Otsuka America Pharmaceutical, Inc.
-
FDA approval · 2016-08-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for aripiprazole from Apotex Corp., authorizing a generic version of the drug. This action represent…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Early Detection and Intervention for the Prevention of Psychosis [NA]
Completed clinical trial from MaineHealth studied early detection and intervention to prevent psychosis and posted results in August 2016 ac…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex [Phase 3]
Phase 3 trial update evaluating lurasidone added to lithium or divalproex for maintenance treatment in Bipolar I Disorder; the study complet…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection? [NA]
A clinical trial update examining cognitive, morphological, and neurobiological changes in elderly people with bipolar disorder. It explores…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Lamotrigine Therapy in Geriatric Bipolar Depression [NA]
This update reports a completed clinical trial evaluating lamotrigine therapy for bipolar depression in elderly patients, with results poste…
-
CLINICAL_TRIALS research · 2016-07-15Clinical Trial Update: fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder [NA]
An fMRI study examining Theory of Mind in schizophrenia and bipolar disorder, with the current trial status listed as unknown.
-
FDA approval · 2016-07-08FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder [NA]
A Massachusetts General Hospital clinical trial evaluated mindfulness-based therapy to improve disrupted sleep in individuals with bipolar d…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. [Phase 3]
A completed Phase 3 study assessing whether Risperidone causes any cognitive or motor effects in youths with several behavioral and developm…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses [NA]
Verona-based clinical trial evaluating physical comorbidity, health behaviors, and health promotion in patients with functional psychoses ha…
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability? [NA]
A clinical trial entry (NCT02805088) from CHU de Reims investigating emotional processing in schizophrenia and bipolar disorder, with the st…